Aflac Delivers Strong Revenue Gains
Insurance provider (NYSE:AFL) revealed its fourth quarter 2024 financial results on Feb. 5, 2025, showcasing notable revenue achievements but falling short of targeted earnings per share (EPS). The company's adjusted EPS was reported at $1.56, missing the estimated $1.62 by 3.7%. Impressively, total revenue climbed to $5.4 billion, surpassing the expected $4.2 billion by 28.6%. Overall, the quarter showcased strong top-line growth, but margin pressures and currency fluctuations affected its bottom line.
Source: Analyst estimates for the quarter provided by FactSet.
Aflac is a leading provider of supplemental insurance in the United States and Japan, focusing on products such as life, cancer, and health insurance. The Japanese market is crucial for the company, contributing significantly to its overall earnings. Aflac's strategic growth areas include innovation and product development and expanding its distribution networks through partnerships.
Source Fool.com
Aflac Inc. Aktie
Leichtes Sell-Interesse bei Aflac Inc., mit mehr Sell- als Buy-Einschätzungen.
Ein Kursziel von 94 € für Aflac Inc. impliziert ein leicht negatives Wachstum gegenüber dem aktuellen Kurs von 95.9 €.
